Back to top

MEI Pharma (MEIP) Crumbles: Stock Falls by 5.3%
March 25, 2014

Read MoreHide Full Article
MEI Pharma, Inc. (MEIP - Free Report) saw a big move last session, as the company’s shares fell more than 5.0% on the day. The move came on pretty good volume too with far more shares changing hands than in a normal session This reverses the recent trend for MEIP as the stock is now up around 17.2% in the past one-month time frame.

The company has seen a flat track record when it comes to current year estimate revisions over the past few weeks. The consensus for earnings hasn’t been in a trend either. This recent price action is discouraging, so make sure to keep a close watch on this firm in the near future, and especially on earnings estimates following the recent slump.

MEIP currently has a Zacks Rank #4 (Sell) while its Earnings ESP is zero.

Some better-ranked stocks in the healthcare sector include Lannett Company, Inc. (LCI - Free Report) , Questcor Pharmaceuticals, Inc. and Shire plc (SHPG - Free Report) . All these stocks carry a Zacks Rank #1 (Strong Buy).   

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

MEI Pharma, Inc. (MEIP) - free report >>

Lannett Co Inc (LCI) - free report >>

Shire PLC (SHPG) - free report >>

More from Zacks Tale of the Tape

You May Like